Skip to main content

Safe and Affordable Drugs from Canada Act of 2025 (S. 641)

Referred to Committee
Introduced 2/19/2025•119th Congress•Senate

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2/19/2025 • Senate

Summary

Safe and Affordable Drugs from Canada Act of 2025

This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.

Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.

An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs.

The FDA must publish a list of approved Canadian pharmacies on its website.

Introduced in Senate • 2/19/2025

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Administrative law and regulatory proceduresCanadaDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGovernment information and archivesPrescription drugsTrade restrictions

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (8)

Party Breakdown

6
Democrats
1
Republicans
1
Independents

Sponsor

S[
Sen. Klobuchar, Amy [D-MN]

Democrat • MN

Sponsored 2/19/2025

Cosponsors (7)

S[
Sen. Grassley, Chuck [R-IA]

R-IA

Joined 2/19/2025

S[
Sen. Baldwin, Tammy [D-WI]

D-WI

Joined 2/19/2025

S[
S[
Sen. Merkley, Jeff [D-OR]

D-OR

Joined 2/19/2025

S[
Sen. Shaheen, Jeanne [D-NH]

D-NH

Joined 2/19/2025

S[

Bill Journey

Originated in the Senate

Introduced

February 19, 2025

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate2/19/2025

Details

Bill TypeS
Current StatusReferred to Committee
Cosponsors7

Sources and method

· Record updated Nov 19, 2026
  • Congress.govLibrary of Congress
    Status, actions, sponsors, cosponsors, committees and text
    Record updated Nov 19, 2026 · Loaded Nov 19, 2026, 8:43 AM ET
  • CRS bill summaryCongressional Research Service, via Congress.gov
    Official summary
    Summary of the “Introduced in Senate” version, Feb 19, 2025 · Loaded Nov 19, 2026, 8:43 AM ET
  • USAspending.govU.S. Department of the Treasury
    Related Federal Spending section
  • FEC filingsFederal Election Commission
    Funding & Lobbying section
  • Lobbying disclosures (LDA)Secretary of the Senate and Clerk of the House
    Funding & Lobbying section

All sources: Public domain (17 U.S.C. § 105) · Method: Data sources → · Campaign finance →

AI-written text on this page is labeled where it appears. It is written from the sources above and is not a source itself. How we analyze data →

Dates shown where the source reports one. “Loaded” is when CIV.IQ last fetched the record.